New and Efficient Synthesis of HCV NS3/4 A Protease Inhibitor Telaprevir-Reference-Cited by-同舟云学术

New and Efficient Synthesis of HCV NS3/4 A Protease Inhibitor Telaprevir

Published:2019-08-30 Issue:33 Volume:4 Page:9523-9528
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Porala Subbanarasimhulu¹²³,Yerrabelly Jayaprakash Rao¹,Kasireddy Venkateshwar Reddy⁴,Yerrabelly Hemasri⁵,Ghojala Venkat Reddy³,Rebelli Pradeep³

Affiliation:

1. Department of ChemistryUniversity College of ScienceSaifabad, Osmania University, Hyderabad Telangana 500004 India.

2. Department of ChemistryJawaharlal Nehru technological University college of engineering, Hyderabad Telangana 500085 India.

3. Department of Research and DevelopmentMSN R&D centre, Pashamylaram Medak Telangana 502307 India.

4. Department of ChemistryCMR Engineering College, JNTUH, Hyderabad Telangana 501401 India.

5. Department of Chemistry Nizam CollegeOsmania University Hyderabad Telangana 500004 India.

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.201902078

Reference18 articles.

1. Impact of past HBV exposure on virological response to combined interferon ribavirin therapy in patients with chronic HCV genotype 4

2. HCV drug discovery aimed at viral eradication

3. Peptidomimetic Therapeutic Agents Targeting the Protease Enzyme of the Human Immunodeficiency Virus and Hepatitis C Virus

4. R. E. Babine S. H. Chen I. Collado G. P. Cristina I. G. John D. Guo L. Jin J. E. Lamar S. P. Raymond N. J. Snyder X. D. Sun M. J. Tebbe F. Victor Q. M. Wang Y. Y. M. Yip R. B. Perni L. Farmer U. S. Patent No. 7820671 B2 2010.

5. Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Ugi reaction as the green alternative towards active pharmaceutical ingredients;Tetrahedron Green Chem;2024-06

2. Amino Acid and Peptide‐Based Antiviral Agents;ChemMedChem;2021-08-03